Showing 1 to 10 of 14 Clinical Trials
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
---|---|---|---|
Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
CFXX489A12101 NCT06562192 ![]() |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Breast Colon and Rectum Non Small Cells - Lung Pancreas |
Dr. Nicolas Plouznikoff Adeline Hamon 514-890-8000 poste 30737 |
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
MK-9999-02A NCT06428409 ![]() |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Colon and Rectum Hepatic Ducts Pancreas |
Dr. Francine Aubin Adeline Hamon 514-890-8000 poste 30737 |
A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers
MK-5909-005 (REJOICE-GI01) NCT06864169 ![]() |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Colon and Rectum Hepatic Ducts Oesophagus Pancreas Stomach |
Dr. Francine Aubin Adeline Hamon 514-890-8000 poste 30737 |
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
MK-9999-02A NCT06428409 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Colon and Rectum Hepatic Ducts Pancreas |
Dr. Victoria Mandilaras Rodrigo Skowronski 514-934-1934 poste 36275 |
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
PAC.3 (A021806) NCT04340141 ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Pancreas |
Dr. Nicolas Marcoux Mélanie Croussette 418-525-4444 poste 22637 |
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX: a Prospective, Pilot Study
PDAC-LIV NCT06349278 ![]() |
CHU DE QUEBEC – UNIVERSITE LAVAL
![]() |
Pancreas |
Dr. Alexandre Brind’Amour Maryse Gingras 418-525-4444 poste 15781 |
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
AT-PANC-101 NCT04002479 ![]() |
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
![]() |
Pancreas |
Dr. Corey Miller Pricille Cleveaux 514-340-8222 poste 24480 |
Quebec Pancreas Cancer Study
QPCS NCT04104230 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Pancreas |
Dr. George Zogopoulos Adeline Cuggia 514-934-1934 poste 76333 |
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
PAC.3 (A021806) NCT04340141 ![]() |
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
![]() |
Pancreas |
Dr. Frédéric Lemay Michelle Roy 819-346-1110 poste 12848 |
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
PAC.3 (A021806) NCT04340141 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
![]() |
Pancreas |
Dr. George Zogopoulos Jacqueline Lewis 514-934-1934 poste 34909 |